CellCarta and Imagene AI are widening a companion-diagnostics collaboration that aims to move AI pathology from the research bench into…
Generate Biomedicines and Roswell Park have dosed the first patient with GB-5267, an armored CAR T built with AI to…
The Shanghai biotech won clearance for NTS231, a compound aimed at a protein that helps tumors survive treatment.
Leipzig's Bayesian network matched tumor board decisions 95.1% of the time, and an audit of its own tables explains why.
An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Massive Bio has appointed a Seoul-based partner to grow its AI clinical trial matching business in Korea, where it has…
The Toronto company raised a Series A co-led by OrbiMed and Qiming Venture Partners USA for AI that reads trial…
A multimodal assistant answers clinical questions about whole gigapixel pathology slides instead of small tissue crops.